Faron´s Annual Report 2023
Faron Pharmaceuticals Oy ("Faron" or the "Company") Faron´s Annual Report 2023 Company announcement, March 26, 2024 TURKU, Finland / BOSTON, Massachusetts - March 26, 2024 - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company pursuing a CLEVER approach to reprogramming myeloid cells to activate anti-tumor immunity in hematological and solid tumor microenvironments, announces today that its Annual Report for the year 2023 and audited financial statements for the accounting period January 1- December 31, 2023 in English,